Although the LAD1 expression rates were significantly higher in CRC patients (particularly in the early stages UICC I+II) compared to IID patients of our cohort, expression of LAD1 could be detected in all blood samples of the three sub-cohorts matching its abundant expression in epithelial organs. This evidence concerns the gene LAD1 and colorectal carcinoma.